| PARP inhibitors: A new era of targeted therapy S Tangutoori, P Baldwin, S Sridhar Maturitas 81 (1), 5-9, 2015 | 172 | 2015 |
| Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer S Tangutoori, BQ Spring, Z Mai, A Palanisami, LB Mensah, T Hasan Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 223-234, 2016 | 58 | 2016 |
| Light-controlled delivery of monoclonal antibodies for targeted photoinactivation of Ki-67 S Wang, G Hüttmann, Z Zhang, A Vogel, R Birngruber, S Tangutoori, ... Molecular Pharmaceutics 12 (9), 3272-3281, 2015 | 50 | 2015 |
| Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation AL van de Ven, S Tangutoori, P Baldwin, J Qiao, C Gharagouzloo, ... Molecular cancer therapeutics 16 (7), 1279-1289, 2017 | 47 | 2017 |
| Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment P Baldwin, AW Ohman, S Tangutoori, DM Dinulescu, S Sridhar International Journal of Nanomedicine, 8063-8074, 2018 | 15 | 2018 |
| Repurposing an erstwhile cancer drug: A quantitative and therapeutic evaluation of alternative nanosystems for the delivery of colchicine to solid tumors S Tangutoori, A Ohta, S Gatley, RB Campbell J. Cancer Sci. Ther 6 (7), 236-246, 2014 | 13 | 2014 |
| Nanoparticle drug delivery system and method of treating cancer and neurotrauma S Tangutoori, S Sridhar US Patent 10,111,871, 2018 | 11 | 2018 |
| Advancing photodynamic therapy with biochemically tuned liposomal nanotechnologies HC Huang, S Mallidi, G Obaid, B Sears, S Tangutoori, T Hasan Applications of Nanoscience in Photomedicine, 487-510, 2015 | 8 | 2015 |
| Abstract A81: A novel nano-formulation for systemic administration of PARPi-olaparib (Nano-Olaparib) for radiosensitization, chemosensitization, and combinatorial therapy in … S Tangutoori, H Korideck, M Makrigiorgos, R Cormack, S Sridhar Molecular Cancer Therapeutics 12 (11_Supplement), A81-A81, 2013 | 6 | 2013 |
| In vitro analysis of PARP inhibitor nanoformulations P Baldwin, S Tangutoori, S Sridhar International Journal of Nanomedicine 13 (sup1), 59-61, 2018 | 5 | 2018 |
| Generation of dose–response curves and improved ic50s for parp inhibitor nanoformulations P Baldwin, S Tangutoori, S Sridhar Cancer Nanotechnology: Methods and Protocols, 337-342, 2017 | 3 | 2017 |
| Nanoparticle drug delivery system and method of treating cancer and neurotrauma S TANGUTOORI, S Sridhar | 3 | 2015 |
| Nanoformulations of PARP inhibitors Olaparib and Talazoparib for targeted cancer therapy P Baldwin, A Ohman, J Thong, S Tangutoori, A van de Ven, R Kumar, ... Cancer Research 76 (14_Supplement), 4335-4335, 2016 | 2 | 2016 |
| Abstract B48: Prostate cancer pre-treatment with nanoformulated Olaparib overcomes radiation resistance AL Ven, S Tangutoori, P Baldwin, J Qiao, C Gharagouzloo, N Seitzer, ... Cancer Research 77 (2_Supplement), B48-B48, 2017 | 1 | 2017 |
| Prostate cancer pre-treatment with nanoformulated olaparib overcomes radiation resistance AL van de Ven, S Tangutoori, P Baldwin, J Qiao, C Gharagouzloo, ... CANCER RESEARCH 77, 2017 | 1 | 2017 |
| PEG-modified cationic liposomes significantly alter the qualitative and quantitative effects of colchicine against murine lung cancer and microvascular endothelial cells S Tangutoori CANCER RESEARCH 69, 2009 | 1 | 2009 |
| Abstract A03: PARP inhibitor nanotherapy for ovarian cancer. P Baldwin, A Ohman, J Thong, S Tangutoori, D Dinulescu, S Sridhar Clinical Cancer Research 22 (2_Supplement), A03-A03, 2016 | | 2016 |
| Abstract B35: Nanoformulations of PAPR inhibitors nanoolaparib and nanotalazoparib for targeted cancer therapy P Baldwin, I Shanmugam, S Tangutoori, A Ohman, D Dinulescu, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), B35-B35, 2015 | | 2015 |
| Abstract AS29: PARP inhibitor nano-therapy in ovarian cancer models S Tangutoori, P Baldwin, J Medina, A Ohman, D Dinulescu, S Sridhar Clinical Cancer Research 21 (16_Supplement), AS29-AS29, 2015 | | 2015 |
| NanoPARPi inhibitors for ovarian and prostate cancer therapy S Tangutoori, P Bladwin, A Ohman, H Korideck, R Cormack, D Dinulescu, ... Cancer Research 75 (15_Supplement), 3670-3670, 2015 | | 2015 |
